Response to Chiasson et al.: Acarbose for the prevention of Type 2 diabetes, hypertension and cardiovascular disease in subjects with impaired glucose tolerance: facts and interpretations concerning the critical analysis of the STOP-NIDDM Trial data

Author: Sawicki P.   Kaiser T.  

Publisher: Springer Publishing Company

ISSN: 0012-186X

Source: Diabetologia, Vol.47, Iss.6, 2004-06, pp. : 976-977

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content